GlucoTrack, Inc. - Common Stock GCTK 深 滬
已收盤 08-01 16:00:00 美东时间
6.23
+0.080
+1.30%
華盛通- 最 高6.4558
- 今 開5.97
- 成交量 6.95万股
- 最 低 5.81
- 昨 收 6.15
- 總市值 337.92万
- 52周最高 3756.00
- 市盈率 靜 --
- 換手率 12.82%
- 52周最低 5.11
- 委 比 -16.96%
- 總股本 54.24万
- 歷史最高 29100.00
- 量 比 1.40
- 振 幅 10.50%
- 歷史最低 5.81
- 每 手 1
- 風險率 0.71%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting
Glucotrack Inc. will present its implantable Continuous Blood Glucose Monitor (CBGM) technology at the 2025 ADCES Annual Meeting in Phoenix, AZ. The CBGM, which measures blood glucose directly from the blood and lasts up to three years, aims to address limitations of current CGM technology by eliminating the need for wearables. Glucotrack will showcase its CBGM at Booth #1724 and present a poster on endocrinologists’ perspectives during the sessi...
07-31 12:30
Market-Moving News for July 21st
XYZ: 10% | Block Will Replace Hess Corp. In The S&P 500 Effective Prior To The Opening Of Trading On Wednesday, July 23 GCTK: 105% | Glucotrack Repurchases Over 90% Of Series A Warrants From $10M
07-21 19:22
Why Block Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
Shares of Block, Inc. (NYSE:XYZ) rose sharply in pre-market trading ahead of th...
07-21 18:04
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers DIH Holding US (NASDAQ:DHAI) shares rose 35.1% to $0.34 during Friday'...
07-19 05:06
GlucoTrack Completes Major Warrant Repurchase
An announcement from GlucoTrack ( ($GCTK) ) is now available. On July 8, 2025, ...
07-08 21:31
Glucotrack Repurchases Over 90% Of Series A Warrants From $10M Public Offering, Advancing Capital Strategy And Diabetes Device Development
Glucotrack, Inc. (NASDAQ:GCTK), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that it has successfully repurchased over
07-08 20:37
Glucotrack Announces Repurchase of Series A Warrants
Glucotrack, Inc. repurchased over 90% of its outstanding Series A Warrants, reducing warrant liability and share dilution. The move aligns with the company's capital strategy and reflects confidence in its long-term implantable blood glucose monitoring system for diabetes patients. The Series A Warrants repurchased totaled approximately 49,700, with the remaining 4,300 expected to be repurchased. The Series B Warrants were previously extinguished...
07-08 12:30
Watching Stocks Involved In Wearable Health Devices; Traders Circulate X Post Saying "RFK says HHS about to launch one of the biggest campaigns in HHS history to encourage Americans to use wearable health devices (like CGMs). his vision is every American wearing "wearable" in 4 years... HUGE COIs here with some of his top advisors & their businesses."
https://x.com/SarahKarlin/status/1937539272392733011
06-25 00:08
GlucoTrack Implements Reverse Stock Split
GlucoTrack ( ($GCTK) ) has shared an announcement. On June 13, 2025, GlucoTrack...
06-16 21:44
GlucoTrack Announces 1-for-60 Reverse Stock Split
An update from GlucoTrack ( ($GCTK) ) is now available. On June 12, 2025, Gluco...
06-12 21:50
